
Univar Solutions Selected as Exclusive US and Canada Distributor for Ingredion Pharmaceutical Starches
Key Takeaways
- Exclusive US/Canada distribution for Ingredion pharmaceutical starches creates a single-channel supply pathway intended to streamline procurement and reduce supplier fragmentation for manufacturers.
- Centralized sourcing supports wet granulation and solid oral dose development by improving access to binders, fillers, and lubricants within a broad specialty excipient network.
Univar Solutions' Ingredients + Specialties division has been appointed as the distributor for Ingredion Pharma Solutions, creating an exclusive distribution channel for pharmaceutical starches within the United States and Canada.
Univar Solutions LLC announced on February 24, 2026 that its Ingredients + Specialties from Univar Solutions division has been appointed as the distributor for Ingredion Pharma Solutions, creating an exclusive distribution channel for pharmaceutical starches within the United States and Canada.1 This agreement integrates a specialized portfolio of functional excipients into an extensive distribution network to assist manufacturers in streamlining their supply chains. This transition provides a centralized source for critical materials, such as wet granulation binders, fillers, and lubricants. By centralizing procurement, development teams can reduce vendor complexity while gaining access to a broader range of high-quality ingredients.
"We are thrilled to enhance our product range while deepening our partnership with Ingredion," said Aaron Lee, global senior vice president of Health & Nutrition for Univar Solutions.1 "Through this agreement, we will expand access to pharmaceutical starches and other functional excipients in the United States and Canada, helping our pharmaceutical and nutraceutical customers address formulation challenges and grow their businesses. This partnership truly underscores our commitment connecting customers to high-quality ingredients and customized market solutions, and we are optimistic that the collaboration will help enhance tableting, softgel, and encapsulation applications."
How does this consolidation of supply impact product development?
The collaboration is intended to move beyond simple ingredient delivery by offering technical sales support and deep market knowledge to solve complex formulation hurdles.1 By leveraging facilities that adhere to current good manufacturing practices and providing regulatory assistance, the arrangement helps development teams navigate compliance requirements while maintaining product quality. This level of technical support is vital for professionals tasked with optimizing the stability and efficiency of modern delivery systems. By combining science and innovation with a leading portfolio of specialties, this partnership seeks to find the solutions needed to safely improve lives and communities.
What specific technical solutions are now accessible through this arrangement?
Manufacturers now have expanded access to a variety of specialized excipients, including gelatin replacements for vegetarian softgel designs and emulsions for encapsulation, according to the release from Univar Solutions.1 This includes specific starch-based products like UNI-PURE F, UNI-PURE FL, UNI-PURE GA, and UNI-PURE WG-220, which are engineered to improve formulation performance and overcome technical challenges. The availability of these materials through a single partner allows development teams to focus on ingredient innovation and the creation of high-value products.
"We are excited to expand our partnership with Ingredients + Specialties from Univar Solutions in the pharmaceutical starches, mannitol, and specialty excipients product space," said Joe Rogus, pharma senior sales manager – United States and Canada for Ingredion.1 "They are a world-class organization with an excellent track record in delivering high-value specialty products and services to pharmaceutical markets. We're confident that this collaboration will drive ingredient innovation and deliver exceptional value to our customers."
Integrating these resources allows for more creative approaches to tablet and capsule manufacturing by combining logistical strength with specialized chemical expertise. This strategic alignment ensures that developers have the necessary tools to improve the safety and effectiveness of their pharmaceutical products in a rapidly evolving market.
What other partnership has Univar Solutions made recently?
Earlier this month, the subsidiary Univar Solutions B.V. announced the expansion of its ingredient portfolio through an exclusive glycolic acid distribution agreement with the CABB Group in select European, Middle Eastern, and African markets.2 At the time, Nick Powell, CEO of Ingredients + Specialties from Univar Solutions said, "We are delighted to announce our partnership with the CABB Group in beauty and personal care and home care and industrial cleaning in EMEA, focusing jointly on efficacy and performance for customers and end consumers," said Nick Powell, CEO of Ingredients + Specialties from Univar Solutions. "This strategic alliance enhances our ability to deliver quality, innovative ingredients, and we are confident that together we can deliver greater value by offering glycolic acid solutions that meet the increasing demand for multi-purpose consumer products in the region."
References
- Univar Solutions.
Univar Solutions Selected as Ingredion Pharma Solutions Distributor in United States and Canada . Press Release. Feb 24, 2026. - Univar Solutions.
Univar Solutions Expands Ingredient Portfolio with Exclusive Glycolic Acid Distribution Agreement in EMEA . Press Release. Feb 18, 2026.




